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INTRODUCTION 
 Chronic kidney disease (CKD) is a worldwide health problem. 
There is a rising incidence of renal failure due to chronic kidney disease 
and this phenomenon is common in both the developed and under 
developed countries. There is a significant mortality and morbidity 
associated with this condition and it drastically reduces the quality of the 
patient’s life.  
 Normal functions of the kidneys can be affected by a variety of 
diseases and medical conditions. These cause a reduction in GFR, 
metabolic imbalances and retention of harmful waste products. A 
majority of patients progress to end stage kidney disease and may require 
dialysis or renal transplantation.  
 Chronic kidney disease leads to a lot of systemic effects that affects 
a variety of systems in the body. The eye also shows changes due to long 
standing kidney disease. Some systemic diseases such as diabetes, 
hypertension and auto immune disorders affect the kidneys as well as the 
eye. Ocular manifestations may arise as a result of the primary diseases 
causing renal failure or as a result of the secondary effects of renal failure 
itself. It is thus very difficult to ascertain whether the systemic effects are 
due to the disease which caused the renal failure or secondary to the 
changes caused by the kidney disease unless the patient is monitored 
continuously throughout the course of the disease. 
     
 
 
 
 
 
 
 
 
 
 
 
CHRONIC KIDNEY DISEASE 
Definition 
 The National Kidney Foundation (NKF) Kidney Disease Outcome 
Quality Initiative (K/DOQI) Work Group set about to develop clinical practice 
guidelines to define chronic kidney disease (CKD) and to classify stages in its 
progression.  
 CKD was thus defined as the presence of kidney damage or decreased 
level of kidney function for three months or more, irrespective of diagnosis.  
Calculation of Glomerular Filtration Rate (GFR) 
 Glomerular Filtration rate is an important element in making a diagnosis 
of chronic kidney disease as well as to assess the progression of the disease. 
Creatinine levels cannot serve as an estimate or indicator of the filtering ability 
of the kidney as it is both filtered in the glomerulus as well as secreted by the 
proximal tubule. Creatinine clearance also fails as an indicator of Glomerular 
filtration rate as it is known to overestimate GFR by around 40% in normal 
individuals. 
  Classic methods for measurements of GFR, including the gold-standard 
inulin clearance, are cumbersome and are not clinically feasible. In adults, the 
normal GFR based on inulin clearance and adjusted to a standard body surface 
area of 1.73 m2 is 127 ml / min / 1.73 m2 for men and 118 ml / min / 1.73 m2 
for women ( with a standard deviation of approximately 20 ml / min / 1.73 m2). 
After age 30, the average decrease in GFR is 1 ml / min / 1.73 m2 per year. 
 Equations based on serum creatinine but factored for gender, age, and 
ethnicity are the best alternative for estimation of GFR. The most commonly 
used formula is the Cockcroft-Gault equation20. This equation was developed 
to predict CrCl, but has been used to estimate GFR. 
 CrCl = [(140-age) x Weight (Kg)]/[S. Cr x 72] [x 0.85 in women] 
 The Cockcroft-Gault formula is reasonably accurate in mild renal 
impairment with a GFR of around 50 ml/min but can overestimate GFR by up 
to 100 per cent when GFR is less than 10 ml/min.  
 The abbreviated MDRD equation21,22 is recommended for routine use 
and requires only serum creatinine, age, gender and race. 
 GFR = 186.3 x (S. Cr)-1.154 x (age)-0.203 x (0.742 if female) x  
(1.21 if black). This formula is more accurate especially at low clearance and in 
preferred to the Cockcroft-Gault method.  
 
 
 
Stages of CKD 
 The Kidney Disease Outcomes Quality Initiative (K/ DOQI)  guidelines 
have classified chronic kidney diseases into five stages.  
Stage 1 :  Normal  or increased glomerular filtration rate  (GFR) but some 
 evidence of kidney damage reflected by microalbuminuria / 
 proteinuria , hematuria or histological changes. 
Stage 2 :  Kidney damage with a mild decrease in GFR  
  (60 -89 ml/min/1.73m2). 
Stage 3 :  Moderate decrease in GFR (30 – 59 ml/min/1.73m2).  
Stage 4 :  Severe decrease in GFR (15 – 29 ml/min/1.73m2). 
Stage 5 :  Is when renal replacement therapy in the form of dialysis or  
  transplantation has to be considered to sustain life.  
 
 
 
 
 
 
 
 
 
EPIDEMIOLOGY OF CHRONIC KIDNEY  
DISEASE IN INDIA 
The exact data of the prevalence of chronic kidney disease in India is not 
widely available. The first published study was from Apollo Hospital, 
Chennai by Dr. M. K. Mani24. It was a population based study, primarily at 
preventing kidney disease particularly by detection and treatment of diabetes 
and hypertension Prevalence of CKD in the surveyed community was 0.16%. 
 Another study was from All India Institute of Medical Sciences by     
Dr. Sanjay Agarwal23. This was a community based study done in urban Delhi 
where 4972 subjects were screened with blood urea and serum creatinine 
estimation with a specific aim to find out the prevalence of CKD. The 
prevalence of CKD,was defined as serum creatinine > 1.8mg% persisting for 
more than 3 months in the absence of any reversible factor.CKD prevalence 
was calculaled  to be 0.79% or 7852 per million population 
 Jha and Modi 26  reported a study from Bhopal from 2002-2005. They 
reported that the average crude and age adjusted incidence rates of End stage 
renal disease were 151 and 232 per million population respectively. 
 A group of nephrologists from Indian Society Of Nephrology started a 
project to analyse the data on chronic kidney disease patients, called Chronic 
Kidney Disease Registry Of India  . 
 Screening and Early Evaluation of Kidney disease (SEEK) was started 
in 2006 by nephrologists from USA and India.This study reported a very high 
prevalence of 17.4% of CKD in the participants. 
 The exact burden of chronic kidney disease in India is not known. 
Studies have shown that  the prevalence of chronic kidney disease ranges  from 
0.78% to 17.4% while the incidence is 151 per million population. 
    
 
 
 
 
 
 
 
 
 
     ETIOLOGY OF CHRONIC KIDNEY DISEASE 
 Renal insufficiency can ensue from a primary renal disease or a systemic 
disease which affects the kidneys. Chronic systemic diseases like diabetes 
mellitus and hypertension are some of the common causes of chronic kidney 
disease. The slow progression of these systemic diseases make it more difficult 
to identify the onset of kidney dysfunction. These are the preventable causes of 
renal failure. Thus continuous and rigorous monitoring of patients with such 
systemic diseases is essential for the early detection of involvement of kidneys. 
  CAUSES OF  CHRONIC KIDNEY DISEASE 1 
Most Common causes 
 
Diabetes mellitus  
Hypertension 
Glomerulonephritis 
Interstitial nephritis  
Hereditary / Congenital disease 
Analgesic nephropathy 
Neoplasms 
  
Less common causes 
Metabolic 
 Cystinosis 
 Oxalosis 
 Nephrocalcinosis 
 Cystinuria 
Vascular 
 Ischemic renal disease 
 Scleroderma 
 Hemolytic uremic disease 
 Postpartum renal failure 
Autoimmune 
 IgA nephropathy 
Dysproteinemias 
 Amyloid 
 Myeloma 
 Cryoglobulinemia 
Hereditary  
 Alport syndrome 
 Fabry disease 
 Tuberous sclerosis 
 
 
Vasculitis  
 Wegeners granulomatosis 
 Polyarteritis nodosa 
Malignancy 
 Renal cell carcinoma 
 Lymphoma 
Structural 
 Cystic disease of kidney 
 Congenital and acquired abnormalities of urinary tract 
 
 
PATHOGENESIS OF OCULAR FEATURES 
 Mild Chronic Kidney Disease patients are mostly asymptomatic 
although biochemical abnormalities may exist already. More severe 
manifestations develop as the GFR declines progressively. The following are 
the multisystemic complications that occur as a result of declining renal 
function and the accompanying ocular features. 
Abnormal calcium and phosphate metabolism   
 There are several biochemical and hormonal abnormalities that occur in 
chronic renal disease that lead to abnormalities in the calcium and phosphate 
metabolism. Elevated levels of PTH1 in blood and hyperplasia1 of the 
parathyroid glands are seen early in the course of renal insufficiency. There is 
increased phosphorus retention by the failing kidney. Compensatory 
hyperparathyroidism results in increased phosphaturia thus maintaining serum 
phosphorus levels. Hyperphosphatemia becomes evident only when the GFR 
decreases to 20% of normal. Decreased production of 1,25- dihydroxyvitamin 
D in the kidney results in decreased absorption of calcium from the intestines. 
Persistent hypocalcemia is a powerful stimulus for the development of 
hyperparathyroidism. Thus hyperphosphatemia and persistant hypocalcemia  
leads to secondary hyperparathyroidism.  
 Extraskeletal calcifications are frequently encountered in patients with 
advanced renal insufficiency and are aggravated by persistent elevation of the 
calcium – phosphate product. If the concentrations of calcium and phosphorus 
rise beyond a critical level, their solubility product is exceeded and 
precipitation occurs in tissues. Visceral deposits are an amorphous or 
microcrystalline compound composed of calcium, phosphate, or magnesium 
whereas arterial deposits consist of calcium hydroxyapatite crystals.2 In 
arteries, calcium is principally deposited in the tunica media and internal elastic 
lamina. Thus metastatic calcification explains the deposits of calcium in cases 
with persistent elevated calcium. 
 Calcification in extraskeletal tissues can also occur due to a process 
known as calciphylaxis. This refers to the development of local calcification 
after minor local trauma in the absence of markedly elevated calcium and 
phosphate levels. It is a condition of induced hypersensitivity in which tissues 
respond to an appropriate challenger with local calcification. Renal failure acts 
as an indirect sensitizing calcifier, as it gives rise to increasing levels of 
parathyroid hormone. Minor tissue injury to the eye being the local challenger 
represented by devitalisation of the interpalpebral limboconjunctival and 
corneal epithelium being the result of markedly decreased tearflow. In these 
cases the calcification decreases after hemodialysis and after renal transplant.  
 Common ocular sites of calcium deposition include the conjunctiva  
(a cause of red eyes in renal patients), and Bowman’s membrane (band 
keratopathy). These deposits tend to increase in extent in patients treated with 
regular dialysis and regress in patients receiving transplanted kidneys.4 
Posterior segment calcification is less common and tends to affect the sclera 
and choroid. Metastatic sclerochoroidal calcifications typically occur as 
bilateral, multifocal, yellow fundus lesions and are usually located 
superotemporally.5 Massive deposition of calcium hydroxyapatite in the 
previtreal space in a patient with Chronic Kidney Disease has also been 
reported. Retinal arteriolar calcification has also been reported in some 
patients.  
Cardiovascular disease 
 Most of the patients with CKD have a higher blood pressure than the 
general population. Hypertension may be the primary inciting factor causing 
renal damage or it may be the consequence of the renal disease. Hypertensive 
retinopathy in varying stages is a common accompaniment in most cases of 
renal failure. 
Anaemia   
 Anemia is defined as a reduction in the oxygen carrying capacity of 
blood, measured in the laboratory as a low hemoglobin concentratioin, or a low 
hematocrit (the percentage of the blood volume that is occupied by red blood 
cells or erythrocytes). It occurs when the balance between the normal rates of 
blood loss and blood production is disturbed. There are three basic mechanisms 
by which this occurs: (1) blood loss, (2) excessive destruction of red blood cells 
(hemolysis), and (3) abnormally low production of red blood cells by the bone 
marrow.  
 In Chronic Kidney Disease, anemia is almost always present, and can be 
a result of any of the mechanisms listed above. However, the typical “anemia 
of chronic renal insufficiency” is a result of a decreased production of red 
blood cells by the bone marrow.  
 This defect in red blood cell production is largely explained by the 
inability of the failing kidneys to secrete the hormone erythropoietin. This 
hormone is a necessary stimulus for normal bone marrow to produce red blood 
cells. In addition, other factors associated with renal failure, including the 
accumulation of so-called uremic toxins, may play a role in depressing bone 
marrow function. Excess stores of aluminum may accumulate in the bone 
marrow of long term dialysis patients and can contribute to anemia as well.  
 Blood loss and red blood cell destruction also frequently contribute to 
the anemia in patients with renal failure. Platelets, which are small constituents 
of blood which aid in blood clotting, do not work normally in uremia. The 
defective blood clotting seen in uremia makes bleeding more common. Rapid 
bleeding causes a rapid decrease in the hematocrit and is a medical emergency. 
Very slow loss of blood can also cause anemia by depleting the body’s stores 
of iron, which the bone marrow uses to produce blood cells.  
 Excessive destruction of red blood cells is also seen in advanced renal 
failure. Normally, red blood cells survive for about four months before being 
destroyed. This life span is reduced in renal failure, probably because of 
chemical effects of uremia and decreased flexibility of the red blood cells. This 
hemolysis is usually mild and a person with a normal bone marrow could easily 
compensate for it by increasing red blood cell production. However, in renal 
failure, the bone marrow’s capacity to compensate is diminished.  
 Anaemia produces a variety of ocular symptoms and signs ranging from 
conjunctival pallor, retinal hemorrhages, disc pallor leading to nutritional 
amblyopia and can also cause retrobulbar neuritis. 
Malnutrition   
 Malnourishment is very common in Chronic Kidney Disease. It is 
mostly due to inadequate intake due to anorexia , acidosis and insulin 
resistance. There is loss of muscle weight and muscle bulk. Low levels of 
serum albumin, transferring and cholesterol have been observed in renal 
failure.  
Sodium and Water balance 
 Sodium and water balance is not affected till very late in the course of 
the disease. Patients are able to maintain a good sodium and water balance until 
their GFR is reduced very severely (below approximately 10ml/min). 
Bleeding diathesis   
 The main factors that contribute the bleeding diathesis in Chronic 
Kidney Disease are anemia, changes in vascular wall and platelet 
abnormalities. Reduced red cell mass or increased vessel luminal diameter 
(mediated by vasodilating effects of prostacyclins and nitric oxide) decreases 
peripheral dispersion of platelets and their contact with the vessel wall.  
 In uraemia, factors in the plasma prevent normal platelet adhesion and 
aggregation by inhibiting platelet membrane receptor – ligand interplay. 
Increased nitric oxide synthesis, mediated by accumulation of 
guanidinosuccinic acid appears to play a central causative role in disrupting 
normal platelet function. These factors cause overt or occult bleeding in various 
systems. In the eye subconjunctival hemorrhage and retinal hemorrhages occur.         
Hypertension 
 Hypertension is frequently found in patients with  primary renal disease.  
The pathogenesis of hypertension of chronic renal diseases generally divided 
into volume dependent and rennin dependent. Several mechanisms are involved 
in the hypertension of chronic renal disease. Renal disease causes an increase 
in renin, secondary hyperparathyroidism, decrease in medullipin levels, 
asymmetric dimethylarginine accumulation and endothelial dysfunction. These 
factors in turn cause an increase peripheral vascular resistance and increase in 
renal vascular resistance which in turn causes an increase in blood pressure. 
OCULAR FEATURES OF CHRONIC  
KIDNEY DISEASE 
Defective vision 
 Chronic Kidney Disease patients can manifest with defective vision due 
to a variety of reasons. The most common cause is cataract which may be due 
to the metabolic changes due to the causative factor or due to renal failure. It 
may also be due to the treatment modalities in the form of steroid which  hasten 
cataract formation. The other reasons are advanced band keratopathy, 
secondary glaucoma, vitreous hemorrhage, retinopathy due to hypertension or 
diabetes 4 , optic neuropathy and infective endophthalmitis or panophthalmitis 
secondary to defective immunity.. Changes in the refractive status can also lead 
to defective vision. Most of the causes of defective vision are treatable.  
Lid Edema   
 Lid edema4 is a common accompaniment in patients with Chronic 
Kidney Disease. It may be the result of the systemic tendency to accumulate 
fluid in all parts of the body. This kind of edema is associated with facial 
puffiness. Lid edema can also occur due to the chronic irritation of the ocular 
surface and lids by the contents in exhaled air13 . 
Conjunctival Congestion ( Red Eye) 
 Uremia refers to the complex and multi-organ clinical manifestations 
caused by accumulation of nitrogenous waste products due to renal failure. 
These waste products can be categorized into three main groups: 1. Small 
molecular weight substances eg. Urea and its subgroup 2. Middle molecular 
weight substances eg. beta2- Macroglobulin 3. Large molecular weight 
substances eg. p-cresol. Some of these uremic toxins can be exhaled through 
different mechanisms causing a fishy ammonia-like smell to the breath  This 
uremic fetor is mainly attributable to the amines and more importantly, 
dimethylamine and trimethlamine. Increased level of some other gaseous 
compounds such as nitric oxide  and hydrogen peroxide  have also been traced 
in exhaled breath air of renal failure patients. All these volatile compounds 
have the potential ability to irritate the ocular surface and ultimately cause 
various ocular manifestations, especially the “red eye”13. The other reason 
could be the chronic inflammatory response to calcium accumulation in the 
conjunctiva4. 
Conjunctival pallor  
 This is due to the anaemia and malnutrition that accompany Chronic 
Kidney Disease.  
 
Conjunctival degeneration  
 Degenerative changes in the conjunctiva is also found in patients with 
Chronic Kidney Disease. These changes on biopsy appear to be of elastotic 
type of degeneration. They are at times accompanied by deposits of calcium. 
Pingecula4 along with a reduction in goblet cell density is a common finding.  
Subconjunctival hemorrhage  
 Bleeding diathesis is found in many patients with renal failure. The 
multiple and complex mechanisms which are the cause of this has been 
discussed above. Due to the propensity for bleeding spontaneously is 
demonstrated by the frequent occurrence of recurrent subconjunctival 
hemorrhage in patients with renal failure. The degree of subconjunctival 
hemorrhage may vary from small innocuous spots to severe hemorrhage which 
involves all quadrants of the conjunctiva along with chemosis. The sclerosed 
conjunctival vessels secondary to hypertension may also rupture due to the 
fluctuating blood pressure leading to subconjunctival hemorrhage. 
Dry Eye  
 There are a variety of factors that contribute to dryness of the eye in 
patients with renal failure. One of the most important factor is the reduced 
Goblet cell density that is associated with renal failure. The other factors act 
mainly by altering the ocular surface causing instability of the tear film. The 
degree of dryness may vary from mild to very severe dryness leading to 
secondary ocular infections. The systemic causative factors like Diabetes may 
also play a primary role in causation of dryness. 
Corneal deposits  
 There is a chalk like material found to be deposited on the cornea. There 
is a clear deposit free zone between the deposit and limbal margin. They are 
predominantly near the area of conjunctival degeneration. These patients show 
an abnormal high serum calcium levels. The clinical picture is similar to white 
limbus girdle of Vogt Type I. it has been found that in patients who undergo 
hemodialysis or those who have underwent renal transplant the deposits 
regress. This could be because of the fact that the secondary 
hyperparathyroidism starts to regress once the inciting factors are altered. If 
allowed to continue the deposits progress more centrally to involve a big 
portion of the cornea and develop into a full fledged band keratopathy.  
Cataract  
 In patients with renal failure cataracts occurs mostly due to the inciting 
factor and also due to the treatment modalities. Renal failure per se does not 
cause cataract with increased frequency. Cataracts in renal failure is due to 
hypocalcemia. This requires long periods of hypocalcemia and the cataracts 
thus formed are of the posterior cortical variety. Cataracts due to the inciting 
factors like diabetes occur with increasing frequency. It is difficult to ascertain 
whether the cataract is due to diabetes or due to the senile changes in patients. 
The other important factor that plays a significant role in cataract formation is 
the use of steroids and other cataractogenic medications in the treatment of 
renal disease. Of these cases of drug induced cataracts steroid induced cataracts 
are very common. 
Glaucoma  
 Secondary glaucoma in the form of neovascular glaucoma may occur in 
patients with diabetes and also in hypertensives who have retinal vessel 
occlusion. 
Retinal Detachment  
 The type of retinal detachment that we come across in patients with 
Chronic Kidney Disease is a bullous retinal detachment. Numerous hypothesis 
have been suggested for retinal detachments-dilutional hyponatremia, severe 
hypertension, ischemic infarction of choroids  and choroidal  spasm. Multiple 
factors may be operable simultaneously. The interesting part is that the retinal 
detachment is reversible when various causes or the complications are managed 
adequately and that includes renal transplantation as well. Past literatures have 
suggested that the occurrence or finding of retinal detachment in renal failure 
patients is an indication for early dialysis.  
  
Retinopathy 
 Diabetic and hypertensive patients show evidence of retinopathy. If 
these disease processes are the main reason for the renal failure then the 
severity of the retinopathy is more. If they are coexistent conditions then there 
is not much difference in the type of retinopathy except for the occurrence of 
more cotton wool spots in renal patients. 
Vitreous hemorrhage. 
 Vitreous hemorrhage is not a common accompaniment in Chronic 
Kidney Disease. Most of the cases of vitreous hemorrhage are due to advanced 
proliferative diabetic retinopathy. Untreated hypertension or accelerated 
hypertension in these patients can also lead to vitreous hemorrhage. The 
bleeding tendency in Chronic Kidney Disease patients and the anemia along 
with the capillary changes can also lead to vitreous hemorrhage.  
Optic neuropathy 
 Anterior and posterior ischemic optic neuropathy can occur in these 
patients. It could also be secondary to diabetic papillopathy or due to 
accelerated hypertension. 
Secondary ocular infection 
 Patients with renal failure are in a state of immune suppression due to 
defective immunity or due to chronic steroid therapy. Hence they are prone to 
secondary infections which can affect the ocular coats or at times may be blood 
borne and get seeded in the vitreous. Vision threatening infections may be 
uncommon but do occur and needed timely and appropriate intervention. 
Rarely patients have to undergo evisceration or enucleation due to the prolific 
infection. 
  
PART - II 
 
 
 
 
 
AIM OF THE STUDY 
 Chronic Kidney Disease affects every organ system including the eye. 
The requirement for a routine ophthalmic examination for all patients with 
chronic kidney disease and its role in the prevention of visual loss cannot be 
over emphasized. The aim of the study is to conduct a thorough ocular 
examination and to study the occurrence of various ocular manifestations 
exhibited by patients with Chronic Kidney Disease and to analyse the findings.  
MATERIALS AND METHODS 
 This is a Cross Sectional, Descriptive, Non interventional, Hospital 
based study. The period of study was for 15 months, from August 2010 to 
October 2011.  
 Institutional Ethical Committee approval for conducting the study was 
obtained. 
 Patients presenting to Department of Nephrology, Stanley Medical 
College diagnosed with Chronic Kidney Disease  were examined for ocular 
manifestations at the Department of Ophthalmology, Stanley Medical College. 
Sampling technique was consecutive and 100 patients (200 eyes) were enrolled 
in this study. 
 Importance of ocular evaluation were explained to the patients. 
Evaluation procedures were  explained and an informed consent was obtained. 
After obtaining consent 200 eyes of the enrolled patients were examined 
thoroughly.    
 Results of blood and urine investigations performed at Nephrology 
department were collected.  
 
 
The following ocular evaluation were conducted. 
1. Relevant ocular history 
2. Best corrected visual acuity  
3. Detailed slit lamp examination of anterior segment 
4. Posterior segment evaluated with indirect ophthalmoscope and 
Slit lamp biomicroscopy using 90D. Hypertensive retinopathy if 
present was graded using Keith, Wagner and Barker classification 
and diabetic retinopathy was graded using ETDRS system. 
5. Schirmer’s test using Whatman filter paper strip. 
6. Intraocular pressure was measured with Goldmann applanation 
tonometer. 
7. Visual field analysis  using Octopus perimeter, B scan 
ultrasonograghy and optical coherence tomography was done 
whereever indicated 
. 
The results thus obtained were  tabulated and analysed. Statistical analysis was 
done using the Chi square test 
 
Inclusion criteria:  
1. All stages of Chronic kidney disease . 
2. Renal transplant recipients. 
3. Duration of renal disease for  more than 3 months. 
4. Age group between  20 years to 70 years. 
Exclusion criteria:  
1.  Cases with renal disease of unknown etiology 
 2.  Cases with acute fulminant disease  
 3.  Cases with known pre-existing ocular disease 
 
 
 
 
 
 
 
 
 
 
OBSERVATION AND DISCUSSION 
 In this study, a total of one hundred cases of Chronic Kidney Disease 
who were referred from  the Department of Nephrology, Stanley Medical 
College, Chennai  to the Department of Ophthalmology  were enrolled in the 
study after obtaining informed consent and were subjected for thorough ocular 
examination .  
AGE INCIDENCE  
 The Age groups of the patients included in the study were as follows. 
Table. 1 :  Age Incidence 
Age Group No. of Cases % 
20 – 29 16 16 
30 – 39 25 25 
40 – 49 21 21 
50 – 59 18 18 
60 – 69 20 20 
  
 The age distribution in the study group was more or less even with the 
patients in the age group 30 – 39 slightly more than the rest of the cohort. 
 
 SEX RATIO 
 Male patients formed 72% of the total patients in the study group. The 
average male : female ratio was 2.6:1. The gender difference was more in the 
age groups 30- 39 and 40 – 49 which showed a ratio of 4:1 and 4.25:1 
respectively. The ratio was almost equal in the age group 50 – 59 which 
showed a ratio of 1.25:1. 
Table. 2  : Sex Ratio 
 
Sex No. Of Cases % 
Males 72 72 
Females 28 28 
 
 STAGES OF CKD IN STUDY POPULATION 
 
The study group consisted of 31 patients with Stage V disease, 21 with 
Stage IV and 19 patients with Stage III disease. 29 patients were evenly 
distributed in groups of stage I,II and post transplant category.  
Table. 3 :  Stages Of CKD In Study Population 
Stage of CKD 
No. of 
Patients 
% 
Stage I 10 10 
Stage II 9 9 
Stage III 19 19 
Stage IV 21 21 
Stage V 31 31 
Post Transplant 10 10 
 
   
 The Study of Ocular evaluation in patients with chronic renal failure 
published in  Nepal Medical College Journal in 2008 by L.Bajracharya et al4  
showed an almost equal distribution of study population in the various stages of 
chronic kidney disease. But in this  study , patients were predominantly placed 
in the advanced stages of the disease.  
 50.9% of patients had stage V disease and 23.67% had stage IV disease 
as per 5 year Cumulative report of  Chronic Kidney Disease Registry of India25 
2010 
 Post renal transplant patients were not included in both of the above 
mentioned studies. 
 
 
INCIDENCE OF HYPERTENSION 
 The study group consisted predominantly of hypertensive patients.  
They constituted 84%  of the patients. Of the 100 patients who were studied 34 
were both hypertensive and diabetic. 
Table 4. Incidence of Hypertension 
Disease No. of patients % 
Hypertensives 84 84 
Non Hypertensives 16 16 
 
 
 
 
 74.7% of patients were hypertensives in the 5 year Cumulative report of  
CKD Registry of India25 2010,  which is comparable to this study. 
INCIDENCE OF DIABETES 
 Diabetic patients constituted about 40% of the study group out of which 
37% were suffering from type II diabetes and only 3% were suffering from 
type I Diabetes. 60% of the patients were nondiabetics. 17 diabetic patients 
were on  Inj.Insulin and the rest were on oral hypoglycemic agents.  
Table. 5  : Incidence of Diabetes 
 No. of Patients % 
Type I 3 3 
Type II 37 37 
Non Diabetics 60 60 
 
 
 
  In the 5 year Cumulative report of  Chronic Kidney Disease Registry of 
India25 2010, 38.4% of the study group had diabetes of which 9.9% belonged to 
type I DM and 90.1% belonged to type II group. This is similar to this study 
were type I diabetics constituted 7.5% of the diabetic population and type II 
constituted 92.5%. 
CAUSE OF CHRONIC KIDNEY DISEASE 
 In this study, out of the 100 patients , 90 patients had chronic kidney 
disease and 10 patients were   renal transplant recipients. 
Table 6. Cause Of Chronic Kidney Disease 
Disease No. of patients % 
HT 47 52.2 
DM & HT 30 33.3 
DM 6 6.7 
Others 7 7.8 
TOTAL 90 100 
 
 Out of the 90  patients suffering from CKD  6 were having only diabetes 
and 47 were  hypertensives. 30 patients had both diabetes and hypertension and 
7 patients had renal disease  due to other causes like Glomerulonephritis, 
Analgesic nephropathy , IgA nephropathy etc.  
 Of the 10 post renal transplant patients, 3 had hypertension, 4 had 
diabetes and hypertension.  
 Hypertension was the single main cause of Chronic Kidney Disease in 
this study contributing to  52.2%. 33.3% of patients had both diabetes and 
hypertension. 
 
 In the  Study of Ocular evaluation in patients with chronic renal failure 
published in  Nepal Medical College Journal in 2008 by L.Bajracharya et al4  
the commonest cause of Chronic Kidney disease was hypertension(36.1%). 
In the 5 year Cumulative report of  Chronic Kidney Disease Registry of 
India25 2010, Diabetic nephropathy was the most common cause of Chronic 
Kidney Disease contributing to 31.2%. Hypertensive nephrosclerosis 
constituted 12.18% . 
OCULAR SYMPTOMS IN PATIENTS WITH CKD 
 With regards to the ocular complaints in patients screened, 59% of 
patients  had no ocular complaints and only 41% complained of some form of 
ocular discomfort . 85.4 % of patients  with  ocular complaints ,  had defective 
vision, 9.8% of patients  had ocular irritation ,2.4% of patients had pain and 
discharge each . 
Table 7.  Ocular Symptoms in Patients with CKD 
TYPE OF COMPLAINT NO. OF EYES % 
Defective  Vision 35 85.4 
Irritation 4 9.8 
Pain 1 2.4 
Redness 1 2.4 
Total  41 100 
 
 
 
  Most of the patients with ocular complaints were having their eyes 
checked for the first time which showed the lack of awareness about the 
potential ocular complications in CKD. 
 In the study done by Easterbrook et al, published in the British journal 
of Ophthalmology (1970),  all patients had excellent visual acuity. Whereas 
L.Bajracharya’s4  study of ocular evaluation in patients with chronic renal 
failure published in  Nepal Medical College Journal in 2008 claimed that 62% 
of patients had defective vision and 29% had ocular  irritation.  
BEST CORRECTED VISUAL ACUITY 
 Best corrected visual acuity was tabulated .71.5% of the total patients 
enrolled were with vision 6/18 or better .In this study, according to WHO 
criteria ,18.5% were visually impaired (6/24 – 6/60) and 10% were in the 
category of legally blind (vision <6/60).  
 This finding is comparable to  the  Study of Ocular evaluation in patients 
with chronic renal failure published in  Nepal Medical College Journal in 2008 
by L.Bajracharya et al4  which showed that  76.6% of patients had good vision 
and patients with impaired vision were 11.7% and those who were legally blind 
were 11.7%. 
Table. 8 : BEST CORRECTED VISUAL ACUITY 
BCVA 
Stage 
I 
Stage 
II 
Stage 
III 
Stage 
IV 
Stage 
V 
Post 
Transplant 
Total 
eyes 
% 
>/= 6/18 14 11 30 30 40 18 143 71.5 
6/24 - 
6/60 
2 3 6 12 12 2 37 
18.5 
< 6/60 4 4 2 0 10 0 20 10 
Total  
      
200 100 
 
Patients with visual acuity less than 6/60 were significant with   
p value<0.05 
 
ANTERIOR SEGMENT FINDINGS IN DIFFERENT STAGES OF 
CHRONIC KIDNEY DISEASE 
 Of the 200 eyes included in the study 160 eyes showed changes in the 
Anterior segment . 57.5% of eyes had cataract , 16.9% of eyes showed lid 
edema and 17.5% of eyes had conjunctival pallor. The other ocular findings 
that were noticed were iridocyclitis, defective  extraocular movements and 
pingecula.  
Table. 9 : Anterior Segment Findings in Different Stages of CKD  
 
Stage 
I 
Stage 
II 
Stage 
III 
Stage 
IV 
Stage 
V 
Post 
Transplant 
Total  
eyes 
% 
Lid edema 4 2 4 8 9 0 27 16.9 
Conj. Pallor 6 2 8 4 8 0 28 17.5 
Pingecula 2 0 0 2 4 0 8 5.0 
Cataract 5 2 10 31 38 6 92 57.5 
EOM  
Restriction 
0 0 0 0 1 0 1 0.6 
Proptosis 0 0 0 0 1 0 1 0.6 
Iridocyclitis 0 0 0 0 0 1 1 0.6 
Band shaped 
Keratopathy 
0 0 1 1 0 0 2 1.3 
Total 17 6 23 46 61 7 160 100.0 
 
PINGECULA 

 
BAND SHAPED KERATOPATHY 
  
CONJUNCTIVAL PALLOR 
 
 
LID EDEMA 
 
 
 
 
 
 
 
 
 
 
 
 CATARACT 
 
 
 
 
  
PLASTIC IRIDOCYCLITIS IN A POSTRENAL TRANSPLANT 
PATIENT ON IMMUNOSUPPRESION 
 
 
DIABETIC PATIENT WITH PROPTOSIS AND EOM RESTRICTION. 
 
  When the incidence of these symptoms in different stages of Chronic 
Kidney Disease were studied it was found that cataract was found in 38 eyes of  
patients with end stage or Stage V renal disease. Stage V group patients also 
exhibited the most number of anterior segment signs ( 61 eyes). In patients with 
stage IV and Stage III renal disease   46 and 23 eyes showed signs. 
 On analysing the findings ,the significant findings in the anterior 
segment were cataract (p <0.02) and conjunctival pallor(p <0.02) .  
 
  
 One  patient , who was a diabetic with stage V CKD ,had proptosis with 
extraocular movement restriction in the left eye. Investigations  revealed 
mucormycosis of the maxillary sinus with orbital involvement. The patient 
underwent surgical debridement  of the sinus with appropriate medical therapy. 
 Plastic iridocyclitis was found in a renal transplant patient with 
transplant dysfunction. The patient was on steroids and other 
immunosupressive  agents. 
 
CATARACT IN PRESENILE PATIENTS 
 
 An observation  of the incidence of cataract in the presenile age group 
(<=50) was done. This showed that of the 65 patients (130 eyes) , 53eyes had 
some form of cataract and 11 eyes  have undergone cataract extraction with a 
posterior chamber intraocular lens in place.  
Table. 10 : Cataract in Presenile Patients 
 No. of eyes % 
Cataractous eyes 53 40.8 
PCIOL 11 8.5 
TOTAL 64 49.3 
 
Thus   49.3% of presenile patients had cataract which is significant. 
 INCIDENCE OF OCULAR SURFACE DISEASE IN CKD 
A reduced Schirmer’s value was noted in 54 eyes and was normal in 146 
eyes. The incidence of ocular surface disease in the study was 27%. 
Table. 11 : Incidence Of Ocular Surface Disease in CKD 
Schirmer's test No. of eyes % 
Reduced 54 27 
Normal 146 73 
 
The presence of ocular surface disease in this study was significant with 
p value <0.01. 
In  the  Study of Ocular evaluation in patients with chronic renal failure 
published in  Nepal Medical College Journal in 2008 by L.Bajracharya et al4 
the presence of dry eye was not a significant finding as only 7.5 % of the 
Chronic Kidney Disease patients had dry eye as compared to 27% in this study. 
. 
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SCHIRMER’S TEST 
 
 
 
  INCIDENCE OF HYPERTENSIVE RETINOPATHY IN CKD 
 In this study there was  a total of 84  patients (168 eyes) with 
hypertension, of which 92 eyes (46%) showed hypertensive changes. 
  43 eyes had Grade III retinopathy making it the most common 
hypertensive  retinopathy. Higher grades of hypertensive retinopathy was found 
in advanced stages of CKD  i.e  24 eyes in stage IV and 23 eyes in stage V. 
 92 eyes (46%) out of the 200 under study showed hypertensive 
retinopathy In the study by L.Bajracharya et al4 48% of total patients had 
hypertensive retinopathy and retinopathy was more common in patients in 
stage IV and Stage V disease which is comparable to this study.  
  Table. 12 :  Incidence of hypertensive retinopathy in CKD 
 
Stage 
I 
Stage 
II 
Stage 
III 
Stage 
IV 
Stage 
V 
Post 
Transplant 
Total 
eyes 
Grade I 
HR 0 2 5 2 5 3 17 
Grade II 
HR 5 2 9 3 8 1 28 
Grade III 
HR 5 4 5 19 8 2 43 
Grade IV 
HR 0 2 0 0 2 0 4 
Total 10 10 19 24 23 6 92 
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GRADE IV HYPERTENSIVE RETINOPATHY 
  
 
INCIDENCE OF DIABETIC RETINOPATHY IN CKD 
 Of the 40 patients (80eyes) with diabetes , 51 eyes i.e., 63.75% exhibited 
some degree of diabetic retinopathy.  
  Diabetic retinopathy was most common in patients with Stage V renal 
disease with  25 eyes out of the 51 eyes belonging to this group followed by 
stage IV having 13 eyes with diabetic retinopathy. 
 8 eyes had advanced diabetic eye disease of which 4 eyes belonged to 
stage V. Proliferative diabetic retinopathy was also more common in stage V 
CKD similar to what was observed in the WESDR study where prevalence of 
PDR was much higher in patients with persistent microalbuminuria. 
 Severe NPDR was the most common stage of diabetic retinopathy which 
was found  in  17 eyes. Second most common diabetic retinopathy was 
moderate NPDR and PDR  having 12 eyes each. 
 Clinically significant macular edema was present in 6 eyes in various 
grades of  Diabetic retinopathy. All of them  belonged to stage V CKD. In the 
Wisconsin Epidemiologic study of Diabetic Retinopathy (WESDR)27,28 the 
presence of gross proteinuria suggestive of CKD was associated with increased 
risk of developing Diabetic Macular Edema so also in this study most of the 
patients with Clinically significant macular edema belonged to advanced 
kidney disease group. 
 
SEVERE NPDR WITH CLINICALLY SIGNIFICANT MACULAR EDEMA 
 
   
PROLIFERATIVE DIABETIC RETINOPATHY   
 
 ADVANCED DIABETIC EYE DISEASE 
 
PDR WITH VITREOUS HEMORRHAGE 

Table. 13 :  Incidence of Diabetic Retinopathy In CKD 
 
Stage 
I 
Stage 
II 
Stage 
III 
Stage 
IV 
Stage 
V 
Post 
Transplant 
Total 
eyes 
Mild NPDR 0 0 0 0 2 0 2 
Moderate 
NPDR 
0 0 0 6 4 2 12 
Severe 
NPDR 2 0 2 7 6 0 17 
Very Severe 
NPDR 
0 0 0 0 0 0 0 
PDR 0 1 2 0 9 0 12 
Advanced 
DR 0 3 1 0 4 0 8 
Total 2 4 5 13 25 2 51 
 
 L.Bajracharya et al4 demonstrated that 88.3% of diabetics had 
retinopathy whereas in this study 63.75% of diabetics had retinopathy. Both the 
studies were similar in the fact that more number of patients in stage V showed 
Diabetic retinopathy. 
 In the Andhra Pradesh Eye Diseases study(APEDS)28 the prevalance of 
diabetic retinopathy was 22.4%. In the  Chennai Urban Rural Epidemiology 
Study (CURES)28 the overall prevalence of diabetic retinopathy among the 
sample of diabetic patients was 17.6% .   
 In this study group of CKD patients with diabetes , the patients with 
diabetic retinopathy is 63.75% which is significantly more when compared to 
diabetic retinopathy prevalence in  diabetic population  without CKD. 
  MACULAR FINDINGS IN STUDY GROUP 
 31 eyes from the study group showed changes in the macula. The most 
common sign was macular edema which was found in 13 eyes. This group had 
a mixed population of diabetic and hypertensive patients. Other common 
findings in the macula were age related macular degeneration changes and 
clinically significant macular edema in diabetic patients. PED,  subretinal 
precipitates and macular hole . 
 Macular edema was more common in stage V CKD. 
 
Table. 14 :  Macular Findings  
 
Stage 
I 
Stage 
II 
Stage 
III 
Stage 
IV 
Stage 
V 
Post 
Transplant 
TOTAL 
EYES 
ARMD  3 0 1 0 3 0 7 
CSME  0 0 0 0 6 0 6 
Macular Edema 
(DM & HT) 0 0 2 1 8 2 13 
PED 0 2 0 0 0 0 2 
Sub Retinal PPT 0 0 0 2 0 0 2 
Macular Hole 1 0 0 0 0 0 1 
Total       31 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MACULAR EDEMA 
 
 
CSME 
MACULAR HOLE 
 
 
 
 
 
 
 
 
 
 
OTHER POSTERIOR SEGMENT FINDINGS 
 When diabetic and hypertensive retinopathies  as well as macular 
symptoms were excluded there were some posterior segment findings exhibited 
by 11 eyes from the study group. 4 eyes had a raised CD ratio. BRVO was 
found in 2 eyes of 2 patients. 3 eyes had disc pallor all of them belonged to 
stage IV. 
Table. 15 :  Other Posterior Segment Findings 
 
Stage 
I 
Stage 
II 
Stage 
III 
Stage 
IV 
Stage 
V 
Post 
Transplant Total 
BRVO 0 0 0 2 0 0 2 
CRAO 0 0 0 0 2 0 2 
RAISED CD 
RATIO 2 0 2 0 0 0 4 
Disc Pallor 0 0 0 3 0 0 3 
   
  Two patients had raised CD ratio. IOP and fields were 
normal in both the patients. B scan was done in patients with m edia 
opacities did not show any positive findings.  
  Old CRAO was found bilaterally in one patient. The patient was  
a hypertensive patient and had grade III hypertensive retinopathy along with 
findings of old CRAO.  
 
BRANCH RETINAL VEIN OCCLUSION 
 
DISC PALLOR 
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RESULTS 
 The age distribution in the study group was more or less even, with the 
patients in the age group 30 – 39 slightly more than the rest. Mean age of the 
patients with chronic kidney disease is 44.2. 
 Male patients formed 72% of the total patients in the study group. The 
average male : female ratio was 2.6:1.  
 Out of 100 patients 90 had CKD in various stages &10 belonged to post 
renal transplant group. The sample  size in each grade of CKD showed more 
patients in stage 5 (31%),  & stage 4 (21%) followed by stage 3 (19%), stage 
1(10%) and stage 2 (9%). 
 The commonest cause of CKD was hypertension in 47% pts (52.2%) 
followed by both diabetes and hypertension in 30 patients (33.3%). Patients 
with only diabetes were 6 patients (6.7%) & with other causes (like IgA 
nephropathy , Analgesic nephropathy  etc.,) were 7 patients (7.8%). 
 Blurring of vision was the most common symptom (85.4% ) . Other 
symptoms were ocular irritation (9.8%) and 2.4% each with discharge & 
redness. 
 10% of patients were legally blind with visual acuity <6/60.  
 Of the 200 eyes included in the study 160 eyes had Anterior segment  
changes. 92 eyes (57.5%) had cataract . Of the 92 eyes 38 eyes were in Stage V 
group  and 31 eyes belonged to Stage IV group. 
 In this study, 65 patients ( 130 eyes)  belonged to less than 50 years 
(presenile age group). 49.3% of presenile patients had cataract. 
 A reduced Schirmer’s value was noted in 54 eyes of the 200 eyes. The 
incidence of ocular surface disease in the study was 27%. 
 84 patients in the study had hypertension (HT alone or along with DM). 
92 eyes out of 200 eyes studied showed hypertensive retinopathy. Higher 
grades of hypertensive retinopathy was more in advanced stages of CKD i.e 24 
eyes in stage IV and 23 eyes in Stage V. Grade III hypertensive retinopathy 
was the most common grade of hypertensive retinopathy occurring in 43 eyes 
of the 92 eyes. 
  40 patients (80 eyes) in the study had Diabetes (DM alone or with 
HT).51 eyes showed Diabetic retinopathy changes of which a majority of 25 
eyes(  belonged to stage V disease. Moderate NPDR and Severe NPDR were 
the most common stages of Diabetic retinopathy with 29 eyes  having either of 
these. Advanced diabetic eye disease was found in 4 patients all belonging to 
stage V CKD.   
 Prevalence of Diabetic retinopathy in CKD patients is significantly more 
when compared to diabetic patients without CKD. 
 31 eyes in the study showed changes in the macula. The most common 
sign was macular edema found in 13 eyes which had a mixed population of 
diabetic and hypertensive patients. 
 Other findings in the posterior segment included 4 eyes with raised CD 
ratio, 2 eyes with BRVO, 2 eyes with old CRAO and 3 eyes with disc pallor. 
 
 
 
CONCLUSION 
 CKD is the end result of multiple systemic diseases or primary renal 
disease. During the natural course of the disease it affects multiple systems of 
the body including the eye. Detailed ocular examination was conducted in 100 
patients in varying stages of CKD. In this study hypertension was the single 
main cause of CKD followed by DM and HT together. 
 Blurring of vision was the commonest ocular symptom. Most of the 
patients having complaints of blurring of vision were examined for the first 
time indicating the lack of knowledge about the potential ocular complications. 
Significant visual loss was due to cataract followed by Proliferative Diabetic 
retinopathy and macular edema. 
 Ocular findings that were   present more in   stage IV & stage V grades 
of CKD were cataract, lid edema, conjunctival pallor, hypertensive retinopathy, 
diabetic retinopathy, macular edema and CSME. 
 Most of the patients are detected in advanced stages of chronic kidney 
disease , when they become symptomatic . Hence it becomes imperative to 
institute steps to detect CKD at an early stage to institute specific therapy and 
retard the progression of renal disease . Eye can be used as a window to the 
kidney status , and detect any underlying renal compromise and institute early 
treatment.   
 Retinopathy is often asymptomatic in its early stage. Delay in diagnosis 
can result in significant visual loss. Optimized control of risk factors like renal 
disease which affect onset and progression of retinopathy should be approached 
through an intensive, multidisciplinary health care which can markedly reduce 
the incidence of visual loss. 
 In this study most of the  patients were having their eyes examined for 
the first time. This shows the lack of awareness of  the importance of  early  
ocular evaluation among the patients.  
 This study is an attempt to assess the ocular status and complications 
associated with chronic kidney disease. It is intended to highlight the 
importance of ocular examination in all patients with chronic kidney disease 
irrespective of the presence of ocular symptoms so that necessary treatment or 
advice can be given before they cause irreversible visual impairment. 
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Ocular manifestations  in patients with Chronic Kidney  
Disease  – a hospital based study 
 
PROFORMA 
 
Serial no.     : 
Name     : 
Age     : 
Sex     : 
Occupation    : 
Address    : 
Ocular complaints   : 
Renal status of patient 
Stage     : 
Duration   : 
Treatment details   : 
Diabetic status  
 Type     : 
 Duration   : 
 Treatment  details   : 
H/o Hypertension    : 
Ass. Systemic illness  : 
  
 
OCULAR EXAMINATION     RE  LE 
Vision 
Eyelids and lashes 
Extraocular movements 
Slit lamp examination 
 Tear meniscus 
Conjunctiva 
Cornea 
Anterior chamber 
Iris  
Pupil 
Lens  
Fundus  
IOP 
Visual fields 
Schirmer’s test 
INVESTIGATIONS 
Bloodsugar  
 Fasting    Post prandial 
Blood urea 
Serum creatinine 
urine : Albumin 
  Sugar 
  Deposits 
KEY TO MASTER CHART 
 
ARMD  –  Age Related Macular Degeneration 
BSK   –  Band Shaped Keratopathy 
CAPD  –  Continuous Ambulatory Peritoneal Dialysis 
CCC   –  Circum Corneal Congestion 
Ce   –  Cells  
CVA   –  Cerebrovascular Accident 
DV   –  Defective vision 
Ex   –  Exudate 
F   –  Female 
Gr   –  Grade 
HD   –  Hemodialysis 
HM   –  Hand Movements 
Ht   –  Hypertension 
IMC   –  Immature Cataract 
LC   –  Lens changes 
Li. Ed.  –  Lid Edema 
M   –  Male  
Mal   –  Malignant 
MC   –  Mature Cataract 
ME   –  Macular Edema 
Mon   – Months 
N   –  Normal 
NPDR  –  Non proliferative Diabetic Retinopathy 
OHA   –  Oral Hypoglycemic Agents 
P   –  Proptosis 
Pal   –  Pallor 
PCIOL  –  Posterior Chamber IntraOcular Lens 
PCO   –  Posterior Capsule opacification 
PDR    -  Proliferative Diabetic retinopathy 
PED   –  Pigment Epithelial Detachment 
Pin   –  Pingecula 
PL   –  perception of Light 
Red   –  reduced 
Res   –  Restricted 
Ret   –  Retinopathy 
St   – Stage 
TRD   –  Tractional Retinal Detachment 
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